The Centers for Medicare and Medicaid Services (CMS) has released a 1,747 page rule with its proposed actions for CY 2022.
Fee Schedule Provisions:
Conversion factors (CF) are proposed to decrease due to two factors:
|
2021 CF |
Proposed 2022 CF |
Percent Change |
Anesthesia |
$21.5600 |
$21.0442 |
(2.39%) |
RBRVS |
$34.8931 |
$33.5848 |
(3.75%) |
Anesthesia Code Updates
The descriptor for code 00537 is unchanged but the code has been revalued and CMS is proposing to increase the base unit value it assigns to this service.
Code |
Descriptor |
Current Base Unit Value |
CMS Proposed Base Unit Value |
00537 |
Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation |
CMS 7 RVG 10 |
10 |
Two anesthesia codes will be deleted and replaced with six new codes that more specifically describe the care.
Deleted |
||
Code |
Descriptor |
Base Unit Value |
01935 |
Anesthesia for percutaneous image guided procedures on the spine and spinal cord; diagnostic |
5 |
01936 |
Anesthesia for percutaneous image guided procedures on the spine and spinal cord; therapeutic |
5 |
New |
||
Code (Placeholder number) |
Descriptor |
Proposed Base Unit Value |
01XX2 |
Anesthesia for percutaneous image-guided injection, drainage or aspiration procedures on the spine or spinal cord; cervical or thoracic |
4 |
01XX3 |
Anesthesia for percutaneous image-guided injection, drainage or aspiration procedures on the spine or spinal cord; lumbar or sacral |
4 |
01XX4 |
Anesthesia for percutaneous image-guided destruction procedures by neurolytic agent on the spine or spinal cord; cervical or thoracic |
4 |
01XX5 |
Anesthesia for percutaneous image-guided destruction procedures by neurolytic agent on the spine or spinal cord; lumbar or sacral |
4 |
01XX6 |
Anesthesia for percutaneous image guided neuromodulation or intravertebral procedures (eg, Kyphoplasty, vertebroplasty) on the spine or spinal cord; cervical or thoracic |
5 |
01XX7 |
Anesthesia for percutaneous image guided neuromodulation or intravertebral procedures (eg, Kyphoplasty, vertebroplasty) on the spine or spinal cord; lumbar or sacral |
5 |
Pain Medicine Code Updates
The codes that describe facet joint ablation underwent review and revaluation as having been identified as potentially misvalued services. The primary codes will see a decrease in work relative value units (RVU) while the associated add-on codes will hold their current value.
Code |
Descriptor |
Current Work RVU |
Proposed Work RVU |
64633 |
Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); cervical or thoracic, single facet joint |
3.84 |
3.31 |
64634 |
Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); cervical or thoracic, each additional facet joint (List separately in addition to code for primary procedure) |
1.32 |
1.32 |
64635 |
Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); cervical or thoracic, each additional facet joint (List separately in addition to code for primary procedure) |
3.78 |
3.32 |
64636 |
Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, each additional facet joint (List separately in addition to code for primary procedure) |
1.16 |
1.16 |
Overall Impact to ASA Members:
The rule includes an estimated specialty specific impact should all provisions be finalized as proposed. Anesthesiology, Interventional Pain Mgmt and Nurse Anesthetists/Anesthesiologist Assistants are slated for a positive 1% impact.
For questions on the fee schedule provisions, please email [email protected].
Quality Payment Program Provisions:
CMS also released its 2022 Quality Payment Program (QPP) Proposed Rule. The proposed rule provides details on how CMS intends for eligible clinicians and groups to participate in the Merit-based Incentive Payment System (MIPS), Alternative Payment Models and other features of the QPP during the 2022 performance year.
For 2022,
ASA is pleased that CMS has proposed an anesthesiology MVP for 2023. CMS believes that MVPs will alleviate some of the reporting burden that anesthesiologists and other physicians encounter and at the same time, improve the care that is delivered to beneficiaries. CMS describes many of these provisions and how MVPs would be scored in the rule. The Anesthesiology MVP is one of just seven proposed for 2023.
For more information on the Quality Payment Program, please contact the ASA Department of Quality and Regulatory Affairs (QRA) at [email protected].
ASA leaders and staff will review the rule and submit comments by the Sept 13, 2021 deadline. Finalized provisions will become effective January 1, 2022.
For More Information: